National Institutes of Health

TitleOrganizationLOI dateDue DateKeywordsFOA
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)National Institutes of Health1/26/20242/26/2024Biomedical Research, Biomedical Informatics, Scholarly Works, Health InformaticsPAR-23-183
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)National Institutes of Health1/16/20242/16/2024Mechanisms, Incretin mimetics, Clinical trial not allowedPAR-23-280
Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)National Institutes of Health1/7/20242/7/2024Chimeric antigen receptor, CAR, AD/ADRD,RFA-AG-24-046
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)National Institutes of Health1/5/20242/5/2024Mechanisms, Cancer risk, Incretin mimetics, Clinical trial optionalPAR-23-279
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)National Institutes of Health10/17/202311/17/2023Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchRFA-RM-23-015
A Consortium for Gut-Brain Communication in Parkinson’s Disease (U24 Clinical Trial not allowed)National Institutes of Health10/16/202311/15/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesRFA-DK-23-001
A Consortium for Gut-Brain Communication in Parkinson’s Disease (U01 Clinical Trial Not Allowed)National Institutes of Health10/16/202311/15/2023Neuroscience, Brain Disorders, Molecular Biology, Gut-Brain AxisRFA-DK-22-036
Network of Genomics-Enabled Learning Health Systems (gLHS) – Clinical Sites (U01 Clinical Trial Required)National Institutes of Health10/6/202311/7/2023Cancer Disparities, Gene Editing, Cancer Health Disparities, Next Generation SequencingRFA-HG-23-041
Network of Genomics-Enabled Learning Health Systems (gLHS) – Coordinating Center (U01 Clinical Trials Required)National Institutes of Health10/6/202311/7/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesRFA-HG-23-042
Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)National Institutes of Health10/6/202312/6/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesRFA-OD-23-021
Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)National Institutes of Health10/3/202311/3/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesRFA-AG-24-026
Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional)National Institutes of Health10/3/202311/3/2023Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresRFA-AG-24-025
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of Health10/2/202311/2/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesPAR-23-242
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of Health10/2/202311/2/2023Nanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-23-243
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of Health10/2/202311/2/2023Research Specialist, Laboratory-based ScientistPAR-23-242
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of Health10/2/202311/2/2023Research Specialist, Core-based ScientistPAR-23-243
Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)National Institutes of Health10/2/20232/2/2024Metabolomics, Clinical Trials, Biomarkers, Cancer ResearchRFA-AG-24-039
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)National Institutes of Health9/6/202310/6/2023Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresPAR-23-229
NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)National Institutes of HealthNanotechnology, Brain Disorders, Biomedical Systems, BiomarkersRFA-RM-23-006
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)National Institutes of HealthPhysician-Scientist, Environmental Contaminants, Immuno-oncology, Cancer Prevention, LimitedPAR-23-077
Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)National Institutes of HealthMyofascial Tissues, Global Health, Genomics, Behavior Change, LimitedRFA-AG-24-045
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)National Institutes of Healthanimal models, Translational research, LimitedPAR-23-281
NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)National Institutes of HealthEarly Independence Awards, Small Research Grants, Digital Pathomics, Investigator-Initiated ResearchRFA-RM-23-004
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)National Institutes of Health9/25/2023Health Careers Opportunity Program, Cancer Symptom Management, Gene Editing, Cancer SurvivorshipPAR-23-069
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)National Institutes of Health10/5/2023Animal models, Translational research, PAR-23-281
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)National Institutes of Health10/5/2023Cancer Health Disparities, Cutting-Edge Technologies, Digital Pathomics, Investigator-Initiated ResearchPAR-23-245
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)?National Institutes of Health10/5/2023Comprehensive Cancer Control, Immunotherapy, Imaging Technology, Cell BiologyPAR-23-170
NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)National Institutes of Health10/5/2023Early Independence Awards, Small Research Grants, Digital Pathomics, Investigator-Initiated ResearchPAR-23-133
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)National Institutes of Health10/5/2023Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresPAR-21-166
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)National Institutes of Health10/5/2023Nanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR21-206
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)National Institutes of Health10/5/2023Nanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-23-273
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)National Institutes of Health10/5/2023Nanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-24-024
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)National Institutes of Health10/5/2023Nanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-23-254
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)National Institutes of Health10/5/2023Translational Research, Mammalian Models, Clinical Trial Not AllowedPAR-23-281
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)National Institutes of Health10/16/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesPAR-24-025
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)National Institutes of Health10/16/2023Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresPAR-22-091
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)National Institutes of Health10/16/2023Nanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-22-160
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed)National Institutes of Health10/27/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health Disparities, LimitedRFA-HL-24-007
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clinical Trial Not Allowed)National Institutes of Health10/27/2023Nanotechnology, Brain Disorders, Biomedical Systems, Biomarkers, LimitedRFA-HL-24-006
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)National Institutes of Health11/3/2023Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresPAR-23-246
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)National Institutes of Health11/3/2023Nanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-23-246
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)National Institutes of Health11/5/2023Cancer Control, Population Sciences, Clinical TrialPAR-21-190
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)National Institutes of Health11/12/2023Diversity, Research Scientist Development, Clinical TrialPAR-21-296
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)National Institutes of Health11/17/2023Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchPAR-23-070
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)National Institutes of Health2/5/2024Biomedical Imaging, In Vivo Imaging, Cancer Detection, Medical Technology, LimitedPAR-23-259
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)National Institutes of Health2/5/2024SBIRT/P, Health Disparities, Clinical Trial, Adult PopulationsPAR-23-270
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)National Institutes of Health2/16/2024Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresPAR-23-255
Advanced Research Projects Agency for Health (ARPA-H) National Institutes of Health3/14/2024Biomedical Research, Health Technology, Disease Prevention, Biotechnology, Limited75N99223S0001
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)National Institutes of Health4/30/2024Population assessment, Tobacco and health, Biospecimen accessPAR-24-027
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not AllowedNational Institutes of Health10/16/2023Cancer Health Disparities, Health Data Analysis, Cancer Surveillance, Investigator-Initiated ResearchPAR-23-075
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)</National Institutes of Health10/16/2023Cancer Immunotherapy, B Cell Malignancies, Immunotherapeutic Interventions, Cancer ResearchPAR-24-022
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)National Institutes of Health10/16/2023Neuroscience, Brain Disorders, Drug Development, Therapeutic AgentsPAR-23-075
NCMRR Early Career Research Award (R03 Clinical Trial Optional)National Institutes of Health3/28/2024Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchPAR-23-029
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01)National Institutes of Health6/05/2023Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchPAR-23-040
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)National Institutes of Health6/05/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesPAR-23-034
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)National Institutes of Health6/12/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesPAR-23-070
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)National Institutes of Health6/12/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesPAR-23-071
Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)National Institutes of Health6/12/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesPAR-23-073
Biology of Bladder Cancer (R01 Clinical Trial Optional)National Institutes of Health6/5/2023Bladder, biology PAR-22-218
>Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)National Institutes of Health6/5/2023Environmental Risks, Community Engagement, PAR-22-210
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)National Institutes of Health6/5/2023Phenotype, biomarkers, premastatic PAR-22-131
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed)National Institutes of Health9/25/2023Biomedical research, Animal models, Clinical trials not allowedPAR-23-039
HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3 - Clinical Trial Optional)National Institutes of Health1/30/2024Bioinformatics, Clinical Trial, device, pain
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)National Institutes of Health2/14/2024Gut, Diet, lipids, biology, early-stage, biochemistry
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)National Institutes of Health2/14/2024Gut, Diet, lipids, biochemistry, biology,
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)National Institutes of Health2/16/2024Investigator-Initiated Research, surgery, early-stage
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)National Institutes of Health2/5/2024Investigator-Initiated Research, surgery,
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)National Institutes of Health4/1/2024Early-stage, innovation,
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)National Institutes of Health10/16/2023Cancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research,
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)National Institutes of Health10/16/2023Cancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research,
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)National Institutes of Health10/5/2023Cancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research,
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)National Institutes of Health12/15/2023Lymphoma, virus, translational, disease progression,
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)National Institutes of Health10/16/2023microbiome, immune response, novel molecules, early-stage
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)National Institutes of Health10/5/2023microbiome, immune response, novel molecules,
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)National Institutes of Health2/5/2024regenerative medicine, biomimetic, tissue engineering, biology, novel models, innovation
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)National Institutes of Health10/16/2023Microbiome, imaging, therapy, immune response, preclinical, bacteria, exploratory
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)National Institutes of Health10/5/2023Microbiome, imaging, therapy, immune response, preclinical, bacteria,
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional)National Institutes of Health7/1/2024transdisciplinary, physician, chemistry, biology, innovation, theory,
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)National Institutes of Health6/20/2024Systems-level, mechanisms of responses. Therapy, novel, data,
Biology of Bladder Cancer (R21 Clinical Trial Optional)National Institutes of Health2/16/2024Exploratory, biology, genetics, novel interventions,
Biology of Bladder Cancer (R01 Clinical Trial Optional)National Institutes of Health2/5/2024biology, genetics, novel interventions,
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)National Institutes of Health12/8/2023Early-stage, predoctoral, training, clinical, fellowship, physician
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)National Institutes of Health12/8/2023Early-stage, predoctoral, training, clinical, fellowship, physician
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)National Institutes of Health1/11/2024Clinical, biology, biomarker, clinical
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)National Institutes of Health11/17/2023Exploratory, Diversity, clinical, early-stage
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)National Institutes of Health12/8/2023Early-stage, predoctoral, training, clinical, fellowship, physician, Diversity,
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)National Institutes of Health2/12/2024Diversity, Research Scientist Development, Clinical Trial
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)National Institutes of Health2/12/2024Diversity, Research Scientist Development, Clinical Trial
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)National Institutes of Health2/12/2024Diversity, Early-stage, training, career transition, postdoctoral, biomedical,
NCI Transition Career Development Award to Promote Diversity (K22  Clinical Trial Required)National Institutes of Health2/12/2024Clinical Trials, Diversity, Early-stage, Career Transition, postdoctoral
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)National Institutes of Health2/13/2024Clinical Trials, Early-stage, diagnosis, precention, disparities, molecules, xenograft, biology
Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)National Institutes of Health12/6/2023Tobacco, communication, Smoke Cessation
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)National Institutes of Health10/5/2023Innovation, population research, occupation, work-place, disparities, diversity, social
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)National Institutes of Health12/11/2023Diet, gut microbiome, obesity, weight, policy,
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)National Institutes of Health2/5/2024collaborative, therapies, basic, translational, clinical, biomarkers,
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)National Institutes of Health6/7/2024Exploratory, Early-stage, cancer control, novel
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)National Institutes of Health10/5/2023Innovation, patient-clinician, communication, disparities, diversity, outcomes, equity
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)National Institutes of Health2/28/2024Established, epidemiology, cancer control
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)National Institutes of Health2/28/2024epidemiology, diversity, risks, rural, poverty, population-based research, cohort
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )National Institutes of Health7/12/2024Early-Stage, Tobacco, postdoctoral,
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)National Institutes of Health2/5/2024Survivor, treatment, diversity, observational
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)National Institutes of Health12/8/2023Fellowship, Postdoctoral, early-stage, mentor,
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)National Institutes of Health10/19/2023genome, novel use, early-stage
Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed)National Institutes of Health11/14/2023sequencing, virus, data, innovation, bioinformatics
Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed)National Institutes of Health11/15/2023Cooperative agreement, microbiome, tissue,

Can’t find what you’re looking for? Please contact Researchadmin@cancer.ufl.edu for assistance in finding additional funding opportunities.

NCI Cancer Center badge